Immunologic Response to HIV Infection: Main Immunopathological Alterations
DOI:
https://doi.org/10.36560/812015121Palavras-chave:
HIV infection, immune response, AIDS, CD4 T cellsResumo
The intense degradation of defense cells caused by the human immunodeficiency virus (HIV) in an organism and the speed at which the viral genome mutates to escape the initial immune response are the prime difficulties in combating opportunistic diseases and in creating an efficient vaccine for this virus. The common opportunistic diseases observed for HIV positive patients include tuberculosis, candidiasis and toxoplasmosis. One of the risk factors is the decrease in CD4+ T-lymphocyte count and the high plasmatic viral load, rendering the organism susceptible to these pathogens. Despite the effectiveness of antiretroviral therapy, this does not provide total elimination of the virus, only eliminating the virus present in the plasma. On treatment withdrawal, the infected latent CD4+ T-cells can re-establish the infection, conferring a large barrier to definitive HIV cure. Current studies have evaluated the inhibition of class I histone diacetylase (HDAC) enzymes as a strategy to induce the viral gene expression and, consequently, the gradual emptying of latent reservoirs of the virus, improving the action of antiretroviral therapy. Thus, the monitoring of immune activation and counting of CD4+ T-lymphocytes are of fundamental importance to the prognosis of HIV patients, along with early diagnoses of opportunistic diseases, in order to avoid complications from these diseases.
Referências
ALFONZO, MA., DIAZ, A., SICILIANO, L., LOPEZ, MG., HUNG, A., GARCIA, JF. Estado funcional dos linfócitos TD4+ e CD8+ e seu papel na progressão lenta da infecção por HIV em pacientes pediátricos. J. Pediatr. (Rio J.) 88: 161-168, 2012. URL: http://www.scielo.br/pdf/jped/v88n2/a11v88n2.pdf
ARCHIN, NM., ESPESETH, A., PARKER, D., CHEEMA, M., HAZUDA, D., MARGOLIS, DM. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retroviruses 25: 207–212, 2009. URL: http://online.liebertpub.com/doi/pdf/10.1089/aid.2008.0191
ARCHIN, NM., VAIDY, NK., KURUCA, JD., LIBERTY, AL., WIEGAND, A., KEARNEY, MF., COHEN, MS., COFFIN, JM., BOSCH, RJ., GAY, CL., ERON, JJ., MARGOLIS, DM., PERELSON, AS. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc. Natl. Acad. Sci. USA 109: 9523-9528, 2012a. URL: http://www.pnas.org/content/109/24/9523.full.pdf+html
ARCHIN, NM., LIBERTY, AL., KASHUBA, AD., CHOUDHARY, SK., KURUC, JD., CROOKS, AM., PARKER, DC., ANDERSON, EM., KEARNEY, MF., STRAIN, MC., RICHMAN, DD., HUDGENS, MG., BOSCH RJ., COFFIN, JM., ERON, JJ., HAZUDA, DJ., MARGOLIS, DM. Administration of Vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 25: 482-485, 2012. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704185/pdf/nihms383721.pdf
BRASIL, Ministério da Saúde. 2013. http://bvsms.saude.gov.br.
BRASIL,Ministério da Saúde.2012. http://portalsaude.saude.gov.br/portalsaude/index.html.
COSSARIZZA, A., BERTONCELLI, L., NEMES, E., LUGLI, E., PINTI, M., NASI, M., DE BIASI, S., GIBELLINI, L., MONTAGNA, JP., VECCHIA, M., MANZINI, L., MESCHIARI, M., BORGHI, V., GUARALDI, G., MUSSINI, C. T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. Public Library of Science 7: 1-12, 2012. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517542/pdf/pone.0050728.pdf
ERIKSSON, EM., KEH, CE., DEEKS, SG., MARTIN, JN., HECHT, FM., NIXON, DF. Differential expression of CD96 surface molecule represents CD8+ T cells with dissimilar effector function during HIV-1 infection. Public Library of Science 7: 1-8, 2012. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521672/pdf/pone.0051696.pdf
JAMAL, LF., MOHERDAUI, F. Tuberculose e infecção pelo HIV no Brasil: magnitude do problema e estratégias para o controle. Rev. Saúde Pública 41: 104-110, 2007. URL: http://www.scielo.br/pdf/rsp/v41s1/6545.pdf
JIANG, Y., CUI, X., CUI, C., ZHANG, J., ZHOU, F., ZHANG, Z., FU, Y., XU, J., CHU, Z., LIU, J., HAN, X., LIAO, C., WANG, Y., CAO, Y., SHANG, H. The function of CD3+CD56+NKT cells in HIV-infected individuals. BioMed Research Internacional 2014: 1-9, 2014. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977420/pdf/BMRI2014-863625.pdf
KHAN, KH. DNA vaccines: roles against diseases. Germs. 3: 26-35, 2013. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882840/pdf/germs-03-01-026.pdf
KLEIN, F., MOUQUET, H., DOSENOVIC, P., SCHEID, JF., SCHARF, L., NUSSENZWEIG, MC. Antibodies in HIV-1 vaccine development and therapy. Science 341: 1199-1204, 2013. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970325/pdf/nihms560651.pdf
LIU, MK., HAWKINS, N., RITCHIE, AJ., GANUSOV, VV., WHALE, V., BRACKENRIDGE, S., LI, H., PAVLICEK, JW., CAI, F., ROSE-ABRAHAMS, M., TREURNICHT, F., HRABER, P., RIOU, C., GRAY, C., FERRARI, G., TANNER, R., PING, LH., ANDERSON, JA., SWANSTROM, R.; CHAVI, CB., COHEN, M., KARIM, SS., HAYNES, B., BORROW, P., PERELSON, AS., SHAW, GM., HAHN, BH., WILLIAMSON, C., KORBER, BT., GAO, F., SELF, S., MCMICHAEL, A., GOONETILLEKE, N. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. The Journal of Clinical Investigation 123: 380-393, 2013. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533301/pdf/JCI65330.pdf
MATALON, S., RASMUSSEN, TA., DINARELLO, C A. Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir. Mol. Med. 17: 466 -472, 2011. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105138/pdf/11_76_matalon.pdf
MCMICHAEL, AJ., BORROW, P., TOMARAS, GD., GOONETILLEKE, N., HAYNES, BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10: 11-23, 2010. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119211/pdf/nihms300023.pdf
MIZIARA, ID., LIMA, AS., LA CORTINA, AC. CandidÃase oral e leucoplasia pilosa como marcadores de progressão da infecção pelo HIV em pacientes brasileiros. Rev. Bras. Otorrinolaringol. 70: 310-314, 2004. URL: http://www.scielo.br/pdf/rboto/v70n3/a05v70n3.pdf
OLIVEIRA, PM., MASCARENHAS, RE., FERRER, SR., OLIVEIRA, RPC., TRAVESSA, IEM., GOMES, MVC., GRASSI, MFR. Vulvovaginites em mulheres infectadas pelo vÃrus da imunodeficiência humana. Rev. Bras. Ginecol. Obstet. 30: 121-126, 2008. URL: http://www.scielo.br/pdf/rbgo/v30n3/3170.pdf
OLIVETTA, E., TIRELLI, V., CHIOZZINI, C., SCAZZOCCHIO, B., ROMANO, I., ARENACCIO, C., SANCHEZ, M. HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation. PLOS ONE 9: 1-21, 2014. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976297/pdf/pone.0093699.pdf
PACE, M.J, GRAF, EH., AGOSTO, LM., MEXAS, AM., MALE, F., BRADY, T., BUSHMAN, FD., O'DOHERTY, U. Directly infected resting CD4+ T cells can produce HIV Gag without spreading infection in a model of HIV latency. Public Library of Science Pathogens 8: 2012. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406090/pdf/ppat.1002818.pdf
PEREIRA, CCA., MACHADO, CJ., RODRIGUES, RN. Perfis de causas múltiplas de morte relacionadas ao HIV/AIDS nos municÃpios de São Paulo e Santos, Brasil, 2001. Cad. Saúde Pública. 23: 645-655, 2007. URL: http://www.scielo.br/pdf/csp/v23n3/23.pdf
RASMUSSEN, TA., SCHMELTZ SØGAARD, O., BRINKMANN, C., WIGHTMAN, F., LEWIN, SR., MELCHJORSEN, J., DINARELLO, C., ØSTERGAARD, L., TOLSTRUP, M. Comparison of HDAC inhibitors in clinical development; effect on HIV production in latently infected cells and T-cell activation. Hum. Vaccin. Immunother. 9: 993-1001, 2013. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899169/pdf/hvi-9-993.pdf
SANTOS, ES., ARAUJO, AF., GALVAO-CASTRO, B., ALCANTARA, LCJ. Diversidade genética do vÃrus da imunodeficiência humana tipo 1 (HIV-1) em mulheres infectadas de uma cidade do nordeste do Brasil. Rev. Bras. Ginecol. Obstet. 31: 609-614, 2009. URL: http://www.scielo.br/pdf/rbgo/v31n12/v31n12a06.pdf
TASCA, KI., CALVI, SA., SOUZA, LR. Immunovirological parameters and cytokines in HIV infection. Rev. Soc. Bras. Med. Trop. 45: 663-669, 2012. URL: http://www.scielo.br/pdf/rsbmt/v45n6/02.pdf
Downloads
Publicado
Como Citar
Edição
Seção
Licença
A revista se reserva o direito de fazer alterações nas regras originais, na ortografia e na ordem gramatical, a fim de manter o idioma de culto padrão, respeitando, no entanto, o estilo dos autores. Os artigos publicados são de propriedade da revista Scientific Electronic Archives, tornando-se sua reimpressão total ou parcial, sujeitos à autorização expressa da direção da revista. A fonte original da publicação deve ser mantida. Os originais não serão devolvidos aos autores. As opiniões expressas pelos autores dos artigos são de sua exclusiva responsabilidade.
The journal reserves the right to make changes to the original rules, spelling and grammatical order, in order to keep the language of worship default, respecting, however, the style of the authors. Articles published are the property of Scientific Electronic Archives magazine, becoming its total or partial reprint, subject to the express authorization of the direction of the journal. The original source of publication should be retained. The originals will not be returned to the authors. Opinions expressed by authors of articles are solely your responsibility.
This journal uses the License Creative Commons Atribuição 4.0 Internacional.
1.png)
